Mitsubishi Tanabe
Market Access/ News/ News/ Top stories
Mitsubishi Tanabe pulls ALS drug from EMA assessment
George Underwood
ALS, ema, Mitsubishi Tanabe, Radicava
0 Comment
X
Mitsubishi Tanabe pulls ALS drug from EMA assessment
https://pharmaphorum.com/news/mitsubishi-tanabe-pulls-als-drug-from-ema-assessment/
FDA approves first ALS treatment for two decades
Richard Staines
ALS, fda, FDA approvals 2017, Mitsubishi Tanabe, neurology, Rare diseases, regulation
0 Comment
FDA asked Mitsubishi to file Radicava following approval in Japan.